The new face of bispecific antibodies: targeting cancer and much more.
about
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.Immunotherapy in acute leukemiaA generic program for multistate protein design.Cancer therapy with bispecific antibodies: Clinical experience.Magnetically Targeted Stem Cell Delivery for Regenerative Medicine.Bispecific antibodies, nanoparticles and cells: bringing the right cells to get the job done.Computationally Designed Bispecific Antibodies using Negative State Repertoires.Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarctionB7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.Self-assembled antibody multimers through peptide nucleic acid conjugation.Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.Antibody-based cancer therapy.Functional analysis of bispecific antibody (EpCAMxCD3)-mediated T-lymphocyte and cancer cell interaction by single-cell force spectroscopy.Homing of annexin-labeled stem cells to apoptotic cells.CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity.Immunotherapies: Exploiting the Immune System for Cancer Treatment.
P2860
Q24644083-4A495ED4-D9C1-4FB3-8E0D-40B54D541F3DQ33368725-409B4D5B-2185-451D-B303-674A2EDBFA67Q33731552-491E6F3C-DA69-4BCD-AC97-2FF6615D115FQ33960287-C86FDA95-6979-42A1-92F0-40F14F00A2BEQ34118856-0A2C84D1-D571-4A06-8850-2B9B556E1387Q36138808-ACFA36A4-656F-479F-B17B-03F76BD3787CQ36600044-B07E7AC7-5BD8-480C-BB44-AA939F18D338Q36899812-24138768-8658-4836-BF4C-06535676A028Q37220758-B647FCB4-1CC0-46B7-82DD-939E1940152BQ37301864-2F7CD545-FE99-4A34-AA35-0E38853BF3B2Q37633102-509A6104-68DD-48D0-B22F-619C45ED8B6AQ38074885-743524FB-D29B-4DCC-B9EA-A902709A274DQ38089186-9A502CE1-70FB-4F12-9C73-C9D9A78EDA85Q39679526-B295530B-CCC6-4436-B2ED-EA0C8B0F52F8Q39931920-49376272-4E72-4FC0-BF8A-FC3EC0BCE089Q46839201-3A3DCC74-7F24-4514-B114-4DF6543A93F2Q55362851-83E9F316-F713-41FC-B4B3-2582896A8754
P2860
The new face of bispecific antibodies: targeting cancer and much more.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The new face of bispecific antibodies: targeting cancer and much more.
@ast
The new face of bispecific antibodies: targeting cancer and much more.
@en
type
label
The new face of bispecific antibodies: targeting cancer and much more.
@ast
The new face of bispecific antibodies: targeting cancer and much more.
@en
prefLabel
The new face of bispecific antibodies: targeting cancer and much more.
@ast
The new face of bispecific antibodies: targeting cancer and much more.
@en
P2093
P1476
The new face of bispecific antibodies: targeting cancer and much more.
@en
P2093
Lawrence G Lum
Pamela A Davol
Randall J Lee
P356
10.1016/J.EXPHEM.2005.07.013
P577
2006-01-01T00:00:00Z